Tirzepatide 10mg research peptide is supplied as a high-purity lyophilized synthetic compound intended for laboratory investigation of incretin receptor signaling pathways. In controlled research environments, this compound is evaluated for interaction with GLP-1 and GIP receptor systems.

We’ve published a detailed research comparison examining Retatrutide vs Tirzepatide in laboratory settings, including receptor targeting differences and signaling pathway considerations.

Read the full comparison here.

Research Applications

• Dual incretin receptor pathway activation

• cAMP signaling modulation

• Receptor coordination modeling

• Metabolic pathway analysis

Its dual receptor targeting profile distinguishes it from triple-agonist compounds studied in related laboratory models.

Retatrutide

Product Specifications

• Compound: Tirzepatide

• Strength: 10mg per vial

• Form: Lyophilized powder

• Purity: Research-grade (see COA)

• Storage: Refrigerated conditions recommended

• Intended Use: Laboratory Research Use Only

Certificate of Analysis

Certificate of Analysis (COA)

Each batch of Tirzepatide 10mg research peptide is verified for purity and identity.

Current Active Batch:ERL-TIRZ-XXXX

View the full Certificate of Analysis here:[View Current COA]Certificate of Analysis

Certificate of Analysis (COA)

Each batch of Tirzepatide 10mg research peptide is verified for purity and identity.

Current Active Batch: # ERL-2501-B015-T

View the full Certificate of Analysis here:

View Current COA

Research Use Notice

Research Use Notice

This compound is supplied strictly for laboratory research use only.

Not for human or animal consumption.

Related Metabolic Research Peptides

Researchers studying Tirzepatide may also examine:

• Retatrutide 20mg – Research Peptide

• AOD-9604 5mg – Research Peptide

• MOTS-C 10mg – Research Peptide